SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-24-000100
Filing Date
2024-05-09
Accepted
2024-05-09 16:33:08
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rvnc-20240331.htm   iXBRL 10-Q 1222474
2 EX-10.3 rvncq124ex103dhollanderoff.htm EX-10.3 28984
3 EX-10.4 rvncq124ex104ejordanofferl.htm EX-10.4 28348
4 EX-10.6 rvncq124ex106non-employeed.htm EX-10.6 15454
5 EX-31.1 rvncq124exhibit311.htm EX-31.1 8683
6 EX-31.2 rvncq124exhibit312.htm EX-31.2 8681
7 EX-32.1 rvncq124exhibit321.htm EX-32.1 5094
8 EX-32.2 rvncq124exhibit322.htm EX-32.2 5132
  Complete submission text file 0001479290-24-000100.txt   7813403

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20240331.xsd EX-101.SCH 58660
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20240331_cal.xml EX-101.CAL 105855
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20240331_def.xml EX-101.DEF 311167
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20240331_lab.xml EX-101.LAB 686014
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20240331_pre.xml EX-101.PRE 506543
91 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20240331_htm.xml XML 1144911
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 24931303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)